Capitalizator.

Capitalize Yourself: Right Data. Real Growth.

Company Analysis

HNVR Insider Trading

Hanover Bancorp, Inc. /MD | State Commercial Banks

Comprehensive Trading Performance Summary

The investment history of corporate insiders at Hanover Bancorp, Inc. /MD provides a unique lens into the internal conviction of the company's leadership. By analyzing SEC Form 4 filings, investors can track how directors and officers are allocating their own capital. High-conviction buying often signals that management believes the current market price significantly undervalues future growth prospects, while strategic selling might occur for personal liquidity or portfolio diversification. Monitoring these shifts in ownership is essential for understanding the alignment between management and shareholders in the State Commercial Banks sector.

Transactions on Chart

Open Full Chart
Filing Date Trade Date Reporting Person Relationship Type Price Qty Total, $ Owned After Change, %
2026-02-09 22:35 2026-02-05 Golden Robert Director SELL $23.56 1,200 $28,270 195,358 -0.6%
2025-11-06 18:21 2025-11-04 Golden Robert Director SELL $21.25 5,000 $106,248 80,769 -5.8%
2025-05-12 23:19 2025-05-08 Golden Robert Director SELL $23.06 16,829 $388,132 42,771 -28.2%
2025-05-08 21:54 2025-05-06 Golden Robert Director SELL $23.04 1,708 $39,360 203,387 -0.8%
2025-05-06 17:18 2025-05-02 Golden Robert Director SELL $23.42 5,323 $124,649 205,095 -2.5%
2025-02-10 23:05 2025-02-06 Golden Robert Director SELL $26.34 5,197 $136,901 210,418 -2.4%
2025-02-06 23:37 2025-02-04 Golden Robert Director SELL $26.64 5,681 $151,314 2,239 -71.7%
2025-02-04 21:47 2025-01-31 Golden Robert Director SELL $26.63 4,772 $127,074 27,920 -14.6%
2024-12-11 21:13 2024-12-10 Katz Michael David M.D. Director SELL $25.53 5,000 $127,650 149,279 -3.2%
2024-12-11 05:24 2024-12-10 Golden Robert Director SELL $25.50 2,500 $63,750 28,345 -8.1%
2024-11-26 17:58 2024-11-22 Sisti Elena Director BUY $23.48 215 $5,048 102,093 +0.2%
2024-08-21 04:32 2024-08-20 Okun Philip A Director BUY $17.14 100 $1,714 39,746 +0.3%
2024-06-15 00:08 2024-06-13 Okun Philip A Director BUY $16.48 1,000 $16,480 39,646 +2.6%
2024-06-13 17:04 2024-06-11 Okun Philip A Director BUY $16.26 1,000 $16,255 38,646 +2.7%
2024-05-06 22:57 2024-05-03 Burke Lance P Officer - EVP & Chief Financial Officer BUY $16.61 175 $2,907 21,946 +0.8%
2024-05-03 16:29 2024-05-01 Burke Lance P Officer - EVP & Chief Financial Officer BUY $16.62 400 $6,648 21,771 +1.9%
2024-05-01 18:19 2024-04-30 Wilcox McClelland W Officer - President BUY $16.60 250 $4,150 81,537 +0.3%
2024-05-01 17:39 2024-04-30 Burke Lance P Officer - EVP & Chief Financial Officer BUY $16.60 200 $3,320 21,371 +0.9%
2024-05-01 17:49 2024-04-30 PUORRO MICHAEL P Director, Officer - Chairman & CEO BUY $16.60 500 $8,300 278,388 +0.2%
2024-04-26 16:34 2024-04-24 Burke Lance P Officer - EVP & Chief Financial Officer BUY $16.78 200 $3,356 21,171 +1.0%
2024-04-25 19:25 2024-04-24 Vivona John P Officer - FSVP & Chief Risk Officer BUY $16.79 200 $3,357 3,200 +6.7%
2024-04-25 19:23 2024-04-23 PUORRO MICHAEL P Director, Officer - Chairman & CEO BUY $16.84 400 $6,736 277,888 +0.1%
2024-04-23 20:59 2024-04-22 Sisti Elena Director BUY $16.95 2,000 $33,900 101,878 +2.0%
2024-04-23 19:30 2024-04-22 Wilcox McClelland W Officer - President BUY $16.91 200 $3,382 81,287 +0.2%
2024-04-23 19:28 2024-04-22 PUORRO MICHAEL P Director, Officer - Chairman & CEO BUY $16.58 200 $3,316 277,488 +0.1%
2024-02-02 22:06 2024-01-31 Golden Robert Director BUY $18.00 500 $9,000 28,728 +1.8%
2024-01-31 23:07 2024-01-29 Sisti Elena Director BUY $18.01 2,750 $49,528 97,761 +2.9%
2024-01-31 00:08 2024-01-29 Katz Michael David M.D. Director BUY $18.02 700 $12,614 145,105 +0.5%
2023-12-08 21:59 2023-12-08 Okun Philip A Director SELL $17.75 1,124 $19,954 32,328 -3.4%
2023-11-09 20:33 2023-11-08 Sisti Elena Director BUY $18.00 265 $4,770 95,011 +0.3%
2023-01-26 22:20 2022-05-11 PUORRO MICHAEL P Director, Officer - Chairman & CEO BUY $21.00 4,820 $101,220 256,543 +1.9%
2022-08-15 22:48 2022-08-11 Katz Michael David M.D. Director BUY $20.06 65 $1,304 65 +100.0%
2022-05-11 19:16 2022-05-11 Wilcox McClelland W Officer - SEVP, C.Lending & Revenue Off. BUY $21.00 5,000 $105,000 59,429 +9.2%
2022-05-11 19:13 2022-05-11 Rouse Alice T Officer - EVP & Chief Risk Officer BUY $21.00 2,000 $42,000 24,487 +8.9%
2022-05-11 19:10 2022-05-11 Diiorio Lisa A Officer - FSVP & Chief Accounting Off. BUY $21.00 1,000 $21,000 14,747 +7.3%
2022-05-11 19:07 2022-05-11 Corbett Kevin Officer - EVP & Chief Credit Officer BUY $21.00 5,000 $105,000 18,438 +37.2%
2022-05-11 19:05 2022-05-11 Burke Lance P Officer - EVP & Chief Financial Officer BUY $21.00 2,000 $42,000 16,934 +13.4%
2022-05-11 18:51 2022-05-11 Sorrenti John R Director BUY $21.00 2,500 $52,500 33,500 +8.1%
2022-05-11 18:49 2022-05-11 Sisti Elena Director BUY $21.00 8,000 $168,000 140,768 +6.0%
2022-05-11 18:46 2022-05-11 Okun Philip A Director BUY $21.00 3,000 $63,000 31,840 +10.4%
2022-05-11 18:44 2022-05-11 Negrin Metin Director BUY $21.00 8,000 $168,000 231,995 +3.6%
2022-05-11 18:40 2022-05-11 Katz Michael David M.D. Director BUY $21.00 5,000 $105,000 142,793 +3.6%
2022-05-11 18:28 2022-05-11 Abraham Varkey Director BUY $21.00 2,500 $52,500 49,134 +5.4%
2022-05-11 18:32 2022-05-11 Golden Robert Director BUY $21.00 5,000 $105,000 59,308 +9.2%
2022-05-11 18:35 2022-05-11 Haspel Ahron H Director BUY $21.00 5,000 $105,000 18,894 +36.0%
2022-05-11 18:24 2022-05-11 PUORRO MICHAEL P Director, Officer - Chairman & CEO BUY $21.00 5,000 $105,000 256,723 +2.0%
2022-05-11 19:12 2022-05-11 Finneran Brian K Officer - President BUY $21.00 2,500 $52,500 87,029 +3.0%
SHOW ENTRIES

How to Interpret $HNVR Trades

Not every insider transaction in Hanover Bancorp, Inc. /MD is a signal for immediate action. Professional investors look for "cluster buying"—when multiple executives simultaneously purchase $HNVR shares on the open market. It is crucial to distinguish between scheduled sales (under Rule 10b5-1) and voluntary increases in ownership, which demonstrate management’s true conviction that the stock is undervalued.

Data Source & Accuracy for HNVR

Insider activity data for Hanover Bancorp, Inc. /MD is streamed in real-time directly from the SEC EDGAR system. We analyze raw Form 4 filings, filtering out technical adjustments and complex derivative transactions. This provides a transparent view of how ownership structure is evolving in $HNVR, allowing you to follow the capital of those with the most intimate knowledge of the company.

UNDERSTANDING THE DATA

FILING DATE: The date and time when the transaction was reported to the SEC. This is when the public first receives the information.

TRADE DATE: The actual day the insider executed the purchase or sale in the market.

INDUSTRY: The specific market sector the company operates in. Useful for identifying broader institutional capital flows across sectors.

OWNED AFTER: The total number of shares held by the insider following the transaction. This highlights the insider's remaining conviction in the company.

CHANGE %: The percentage increase or decrease of the insider's total position. Large percentage changes often carry more weight than the dollar amount alone.

TRADE TYPES DEFINITIONS

BUY: An open market purchase. Typically indicates an insider's belief that the stock is undervalued or poised for growth.

SELL: An open market sale. While often used for diversification or liquidity, large or unexpected sales can be a warning signal.

OPT+S (OPTION EXERCISE & SALE): This occurs when an insider exercises their stock options and sells them immediately. Often part of a structured compensation plan.